PACIRA BIOSCIENCES INC. - COMMON STOCK

Pacira to Report First Quarter 2021 Financial Results on Tuesday May 4, 2021

21 أبريل 2021 07:30:00 بحسب Nasdaq GlobeNewswire

Pacira BioSciences Announces Investment in Spine BioPharma

20 أبريل 2021 07:30:00 بحسب Nasdaq GlobeNewswire

Pacira BioSciences Seeks Court Injunction to Protect Clinical Integrity of EXPAREL in the Face of Scientifically Flawed and Misleading Information Published in Anesthesiology

14 أبريل 2021 16:00:00 بحسب Nasdaq GlobeNewswire

Pacira Reports Preliminary Net Product Sales of $118.7 Million for the First Quarter of 2021

07 أبريل 2021 08:00:00 بحسب Nasdaq GlobeNewswire

Pacira Announces FDA Approval of Supplemental New Drug Application for EXPAREL® (bupivacaine liposome injectable suspension) in Pediatric Patients

22 مارس 2021 18:42:22 بحسب Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $36.2 Million for February 2021

09 مارس 2021 08:00:02 بحسب Nasdaq GlobeNewswire

Pacira BioSciences to Present at the 2021 Barclays Global Healthcare Conference

03 مارس 2021 07:30:00 بحسب Nasdaq GlobeNewswire

Pacira BioSciences Reports Full-Year and Fourth Quarter 2020 Financial Results

25 فبراير 2021 08:00:03 بحسب Nasdaq GlobeNewswire

Pacira to Report 2020 Financial Results on Thursday February 25, 2021

18 فبراير 2021 07:30:00 بحسب Nasdaq GlobeNewswire

Pacira BioSciences Reports Preliminary Net Product Sales of $36.0 Million for January 2021

10 فبراير 2021 07:00:00 بحسب Nasdaq GlobeNewswire